abstract |
The present invention relates to RNAi agents such as double-stranded RNAi agents that target the apolipoprotein C3 (APOC3) gene, and methods of using such RNAi agents to inhibit APOC3 expression and to treat patients with APOC3-related disorders such as hypertriglyceridemia tester's method. |